期刊文献+

玉屏风颗粒治疗婴幼儿毛细支气管炎干预其哮喘发病率的临床研究 被引量:3

Clinical study on Yu Ping Feng particle in treatment of capillary bronchitis againstinfant asthma
下载PDF
导出
摘要 目的探讨玉屏风颗粒治疗毛细支气管炎并阻止其发展成哮喘的干预效果。方法将2008年5月-2010年8月住院治疗的176例符合毛细支气管炎诊断标准的患儿随机分成干预组与对照组,对照组予常规治疗,干预组在常规治疗基础上加服玉屏风颗粒3月,对比两组婴幼儿哮喘的发病率及IgE水平。结果干预组89例婴幼儿哮喘10例(11.23%),对照组87例婴幼儿哮喘27例(31.03%),干预组治疗后的IgE值明显较对照组低。结论玉屏风颗粒在干预小儿毛细支气管炎后发展成婴幼儿哮喘有肯定的作用,能明显降低哮喘发病率。 Objective To observe the therapeutic effects of Yu Ping Feng particle in treatment for capillary bronchitis, in order to prevent asthma development.Methods 176 cases of capillary bron- chitis collected from May 2008 to Aug 2010 in our hospital were randomly divided into intervention and control groups and compared the incidence and serum IgE levels.Results The infant asthma incidence rate in intervention group (89 cases) was 11.23% (10 cases). While the one in control group (87 cases) was 31.03% (27 cases). Compared with control Group, serum IgE levels of intervention group declined obviously. Conclusion Yu Ping Feng Particle plays a positive role on preventing capillary bronchitis from devel-oping into Asthma.
出处 《国际医药卫生导报》 2012年第6期817-819,共3页 International Medicine and Health Guidance News
关键词 玉屏风颗粒 毛细支气管炎 哮喘 Yu Ping Feng particle Capillary bronchitis Infant asthma
  • 相关文献

参考文献8

二级参考文献77

  • 1龙全江,徐雪琴,胡昀.白术的化学、药理与炮制研究进展[J].中国中医药信息杂志,2004,11(11):1033-1034. 被引量:67
  • 2张磊,吴瑕,王岚,李东晓,周训伦.玉屏风散多糖类成分对免疫功能的影响[J].中药药理与临床,2006,22(1):2-4. 被引量:96
  • 3Leung TF, Wong GW. The Asian side of asthma and allergy. Curr Opin Allergy Clin Immunol,2008,8 (5) :384-390.
  • 4Piippo-Savolainen E, Korppi M. Wheezy babies wheezy adults? Review on long-term outcome until adulthood after early childhood wheezing. Aeta Paediatr,2008,97 ( 1 ) :5-11.
  • 5Jackson D J, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in highrisk children. Am J Respir Crit Care Med,2008,178 (7) :667- 672.
  • 6Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med, 2000,161(5) :1501-1507.
  • 7Glezen WP,Taber LH,Frank AL,et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child, 1986,140 ( 6 ) : 543-546.
  • 8Robinson RF. Impact of respiratory syncytial virus in the United States. Am J Health Syst Pharm, 2008,65 ( 23 Suppl 8 ) : S3-S6.
  • 9Wu P, Dupont WD, Griffin MR, et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Resoir Crit Care Med,2008,178 ( 11 ) : 1123-1129.
  • 10Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet, 1999,354 (9178) :541-545.

共引文献223

同被引文献51

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部